Cargando…

Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug–Drug Interaction in Healthy Volunteers

In this study, we aimed to evaluate the utility of endogenous 1β-hydroxy-deoxycholic acid/total deoxycholic acid ratio (1β-OH-DCA/ToDCA) in spot urine as a surrogate marker of cytochrome P450 3A (CYP3A) activity in the assessment inhibition-based drug–drug interactions in healthy volunteers. This wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xue-Qing, Thelingwani, Roslyn Stella, Bertilsson, Leif, Diczfalusy, Ulf, Andersson, Tommy B., Masimirembwa, Collen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224742/ https://www.ncbi.nlm.nih.gov/pubmed/34073662 http://dx.doi.org/10.3390/jpm11060457

Ejemplares similares

Analytical validation of GenoPharm a clinical genotyping open array panel of 46 pharmacogenes inclusive of variants unique to people of African ancestry
por: Kanji, Comfort Ropafadzo, et al.
Publicado: (2023)

In vitro and in vivo human metabolism and pharmacokinetics of S‐ and R‐praziquantel
por: Kapungu, Nyasha Nicole, et al.
Publicado: (2020)

Clinically relevant enantiomer specific R‐ and S‐praziquantel pharmacokinetic drug‐drug interactions with efavirenz and ritonavir
por: Mutiti, Chenai Sheilla, et al.
Publicado: (2021)

Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients
por: Molanaei, Hadi, et al.
Publicado: (2018)

CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations—Implication for Drug Safety, Dosing, and Individualized Therapy
por: Langmia, Immaculate M., et al.
Publicado: (2021)

African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development
por: Rajman, Iris, et al.
Publicado: (2017)

Investigation into CYP3A4-mediated drug–drug interactions on midostaurin in healthy volunteers
por: Dutreix, Catherine, et al.
Publicado: (2013)

The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker?
por: Magliocco, Gaëlle, et al.
Publicado: (2021)

Studies on CYP3A activity during the menstrual cycle as measured by urinary 6β‐hydroxycortisol/cortisol
por: Bergström, Helena, et al.
Publicado: (2021)

Pharmacokinetics of Tamoxifen and Its Major Metabolites and the Effect of the African Ancestry Specific CYP2D6*17 Variant on the Formation of the Active Metabolite, Endoxifen
por: Kanji, Comfort Ropafadzo, et al.
Publicado: (2023)

CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe
por: Dhoro, Milcah, et al.
Publicado: (2015)

Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects
por: Matimba, Alice, et al.
Publicado: (2009)

CYP2B6 Genotype‐Dependent Inhibition of CYP1A2 and Induction of CYP2A6 by the Antiretroviral Drug Efavirenz in Healthy Volunteers
por: Metzger, Ingrid F., et al.
Publicado: (2019)

Prevalence and risk factors for efavirenz-based antiretroviral treatment–associated severe vitamin D deficiency: A prospective cohort study
por: Nylén, Hanna, et al.
Publicado: (2016)

Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients.
por: Antonopoulou, Smaragdi, et al.
Publicado: (2003)

No Impact of Vitamin D on the CYP3A Biomarker 4β-Hydroxycholesterol in Patients with Abnormal Glucose Regulation
por: Mannheimer, Buster, et al.
Publicado: (2015)

Community burden of undiagnosed HIV infection among adolescents in Zimbabwe following primary healthcare-based provider-initiated HIV testing and counselling: A cross-sectional survey
por: Simms, Victoria, et al.
Publicado: (2017)

Drug-Drug Interaction Analysis of Pyronaridine/Artesunate and Ritonavir in Healthy Volunteers
por: Morris, Carrie A., et al.
Publicado: (2012)

Drug‐Drug Interaction Study of Apixaban with Cyclosporine and Tacrolimus in Healthy Volunteers
por: Bashir, Babar, et al.
Publicado: (2018)

Effect of clopidogrel on the hydroxylation and sulfoxidation of omeprazole: A single dose study in healthy human volunteers
por: Ahmad, Lateef, et al.
Publicado: (2017)

Simulation of metabolism-based herb-drug interaction: towards safe and efficacious use of NIPRD-AM1
por: Adzu, Bulus, et al.
Publicado: (2013)

Reviewing the role of healthy volunteer studies in drug development
por: Karakunnel, Joyson J., et al.
Publicado: (2018)

Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers
por: Lesko, Lawrence J., et al.
Publicado: (2017)

Evaluation of drug interactions of saxagliptin with sildenafil in healthy volunteers
por: Mansour, Rania Y., et al.
Publicado: (2022)

Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers
por: Ribeiro, Isabela, et al.
Publicado: (2021)

Evaluation of Safety and Clinically Relevant Drug–Drug Interactions with Tucatinib in Healthy Volunteers
por: Topletz-Erickson, Ariel, et al.
Publicado: (2022)

Sodium deoxycholate-decorated zein nanoparticles for a stable colloidal drug delivery system
por: Gagliardi, Agnese, et al.
Publicado: (2018)

Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4β-Hydroxycholesterol/Cholesterol Ratio
por: Mlugu, Eulambius M., et al.
Publicado: (2022)

Effects of Maribavir on P‐Glycoprotein and CYP2D6 in Healthy Volunteers
por: Song, Ivy H., et al.
Publicado: (2019)

Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers
por: Lee, Hae Won, et al.
Publicado: (2020)

Evaluation of antioxidant potential of Rasayana drugs in healthy human volunteers
por: Kuchewar, Vaishali V., et al.
Publicado: (2014)

Healthy Volunteer Studies in the Development of Anticancer Drugs with Genotoxic Findings
por: Omes-Smit, Grace, et al.
Publicado: (2021)

Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers
por: Lee, Hae Won, et al.
Publicado: (2022)

Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs
por: Darnaud, Léa, et al.
Publicado: (2023)

ON THE MECHANISM OF DRUG HYDROXYLATION IN RAT LIVER MICROSOMES
por: Orrenius, Sten
Publicado: (1965)

Hydroxylation index of omeprazole in relation to CYP2C19 polymorphism and sex in a healthy Iranian population
por: Payan, Maryam, et al.
Publicado: (2014)

A cost effective RFLP method to genotype Solute carrier organic anion 1B1 (SLCO1B1) c.1929A>C (p.Leu643Phe, rs34671512); a variant with potential effect on rosuvastatin pharmacokinetics
por: Soko, Nyarai D., et al.
Publicado: (2018)

Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders
por: Johansson, Susanne, et al.
Publicado: (2016)

Altered Microbial Composition of Drug-Sensitive and Drug-Resistant TB Patients Compared with Healthy Volunteers
por: Valdez-Palomares, Fernanda, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic drug–drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers
por: Kim, Dasohm, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_58imcqrgq8v38ugocmbve7ur52